SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-054461
Filing Date
2021-11-04
Accepted
2021-11-04 16:01:43
Documents
14
Period of Report
2021-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K onct-8k_20211104.htm   iXBRL 8-K 38865
2 EX-99.1 onct-ex991_6.htm EX-99.1 182500
3 GRAPHIC gvhqjzhrvxag000001.jpg GRAPHIC 7888
  Complete submission text file 0001564590-21-054461.txt   374965

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA onct-20211104.xsd EX-101.SCH 5689
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20211104_lab.xml EX-101.LAB 19328
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20211104_pre.xml EX-101.PRE 11491
7 EXTRACTED XBRL INSTANCE DOCUMENT onct-8k_20211104_htm.xml XML 3564
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 211379799
SIC: 2834 Pharmaceutical Preparations